InvestorNewsBreaks – Healthtech Solutions Inc. (HLTT) Enters Precision Oncology Market Through Strategic Acquisition

April 30, 2021 14:44:29
Healthtech Solutions (OTC: HLTT), focused on acquiring and investing in strategic cutting-edge health care technological opportunities, recently expanded its portfolio in a move that facilitated entry into the precision cancer care market. Varian Bio was added to the Healthtech Solutions’ umbrella via the parent company acquiring a wholly owned subsidiary, Healthtech Oncology Inc., which will own a 100% interest in Varian Bio. This move adds Varian Bio to HLTT’s growing portfolio to join MediScan Inc., a developer of technology that converts 2D images from portable ultrasound machines into digital 3D images, and RevHeart, a company advancing critical research into the treatment of COVID-related heart muscle injury. “Varian is in the pre-clinical stages of developing two aPKC iota inhibitors in user-preferred delivery methods to treat cancer. VAR-101 is being designed as a topical formulation for the treatment of basal cell carcinoma, the most common type of skin cancer, with about 3.6 million diagnoses each year in the U.S.,” reads a recent article. “VAR-102 is an oral formulation being developed for treating an array of solid tumors where there is existing evidence aPKCi inhibition would be beneficial, such as pancreatic, colorectal and non-small cell lung cancers (“NSCLC”). These indications represent areas of unmet need, as the fourth, third and second leading cause of cancer deaths, respectively, in the U.S. annually.” To view the full article, visit About Healthtech Solutions Inc. Healthtech Solutions is a reporting public company. The board of directors is focusing the company’s resources into creating a platform to acquire and/or invest in cutting-edge health care technology in the medical device biopharma and pharmaceutical fields. The goal is to bring these solutions to market. To date, Healthtech Solutions has invested in three areas of medical technology breakthrough:
  • MediScan Inc., which is developing a technology that converts 2D images from a portable ultrasound machine into digital 3D images to provide better diagnosis and more accurate internal trauma views. The goal is a commercial system that can provide the data equivalent to an X-ray, MRI or CT scan, without radiation and at a lower cost.
  • RevHeart Inc., which is advancing critical research into the treatment of COVID-related heart muscle injury.
  • Varian Biopharmaceutical Inc., a precision oncology company, is the first acquisition of Healthtech Oncology Inc.
Healthtech Solutions has a pipeline of additional acquisitions currently under due diligence. NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork.